Details for New Drug Application (NDA): 209207
✉ Email this page to a colleague
The generic ingredient in IBUPROFEN is ibuprofen sodium. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen sodium profile page.
Pharmacology for NDA: 209207
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 209207
Suppliers and Packaging for NDA: 209207
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IBUPROFEN | ibuprofen | SUSPENSION;ORAL | 209207 | ANDA | TARGET Corporation | 11673-349 | 11673-349-01 | 1 BOTTLE in 1 CARTON (11673-349-01) / 240 mL in 1 BOTTLE |
IBUPROFEN | ibuprofen | SUSPENSION;ORAL | 209207 | ANDA | TARGET Corporation | 11673-349 | 11673-349-08 | 1 BOTTLE in 1 CARTON (11673-349-08) / 120 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SUSPENSION;ORAL | Strength | 100MG/5ML | ||||
Approval Date: | Jun 27, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription